Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Dermatology

Dermatology current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk

June 2024

Acne scarring: pathophysiology, diagnosis, prevention and education 10.1016/j.jaad.2022.04.021; procedural and surgical treatment modalities 10.1016/j.jaad.2022.04.022

Adding fuel to the fire? The skin microbiome in atopic dermatitis 10.1016/j.jid.2024.01.011

Anatomic subtype differences in extramammary Paget disease: a meta-analysis 10.1001/jamadermatol.2024.0001

Atopic dermatitis itch: scratching for an explanation 10.1016/j.jid.2023.10.048

Barriers and facilitators affecting long-term antibiotic prescriptions for acne treatment 10.1001/jamadermatol.2024.0203

Debridement for surgical wounds (updated Cochrane intervention review) 10.1002/14651858.CD006214.pub5

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: diagnosis and management 10.1016/j.jaad.2023.02.073; epidemiology, pathogenesis, clinicopathological features, and prognosis 10.1016/j.jaad.2023.02.072

Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer (new NICE guidance IPG784)

Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients 10.1001/jamadermatol.2024.0021

From GWASs toward mechanistic understanding with case studies in dermatogenetics 10.1016/j.jid.2024.03.013

Genetic and immunological pathogenesis of atopic dermatitis 10.1016/j.jid.2023.10.019

Genetic tools for cell lineage tracing and profiling developmental trajectories in the skin 10.1016/j.jid.2024.02.006

Human leukocyte antigens and sulfamethoxazole/cotrimoxazole–induced severe cutaneous adverse reactions: a systematic review and meta-analysis 10.1001/jamadermatol.2024.0210

IL-17 control of cutaneous immune homeostasis 10.1016/j.jid.2023.11.016

Immunobiology of IL-26 10.1016/j.jid.2023.10.038

A narrative review: opportunities and challenges in artificial intelligence skin image analyses using total body photography 10.1016/j.jid.2023.11.007

Patient-reported outcome measures for health-related quality of life in patients with psoriasis: a systematic review 10.1001/jamadermatol.2023.5439

Preclinical atopic dermatitis skin in infants: an emerging research area 10.1016/j.jid.2024.02.021

Skin barrier in atopic dermatitis 10.1016/j.jid.2024.03.006

Staphylococcus aureus: the bug behind the itch in atopic dermatitis 10.1016/j.jid.2024.01.001

Sources

Cochrane Library (Apr-May); JAMA Dermatology (Apr-May); Journal of Investigative Dermatology (May-Jun); Journal of the American Academy of Dermatology (May-Jun); NICE website (Apr-May)

April 2024

The Alopecia Areata Severity and Morbidity Index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity 10.1001/jamadermatol.2023.5869

Artificial intelligence in skin cancer diagnosis: a reality check 10.1016/j.jid.2023.10.004

Causes and clinical presentation of drug-induced dermatomyositis 10.1001/jamadermatol.2023.5418

Clinical features and outcomes of black patients with melanoma 10.1001/jamadermatol.2023.5789

Compression for preventing recurrence of venous ulcers (updated Cochrane intervention review) 10.1002/14651858.CD002303.pub4

Efficacy and safety of PF-07038124 in patients with atopic dermatitis and plaque psoriasis 10.1001/jamadermatol.2023.4990

Erythromelalgia: pathogenesis, clinical features, evaluation, and complications 10.1016/j.jaad.2023.02.071; differential diagnoses and management 10.1016/j.jaad.2023.02.070

Federated learning for decentralized artificial intelligence in melanoma diagnostics 10.1001/jamadermatol.2023.5550

Genetic risk factors for early-onset Merkel cell carcinoma 10.1001/jamadermatol.2023.5362

Human hair graying revisited: principles, misconceptions, and key research frontiers 10.1016/j.jid.2023.09.276

Lived experience of acne and acne treatment in transgender patients 10.1001/jamadermatol.2023.5355

Nail psoriasis and nail lichen planus: updates on diagnosis and management 10.1016/j.jaad.2023.11.024

Pachyonychia congenita: a research agenda leading to new therapeutic approaches s10.1016/j.jid.2023.10.030

Petroleum jelly: a comprehensive review of its history, uses, and safety 10.1016/j.jaad.2023.06.010

Prevalence of pretreatment testing recommended for patients with chronic inflammatory skin diseases 10.1001/jamadermatol.2023.5895

Proteolytic and antiproteolytic activity in the skin: gluing the pieces together 10.1016/j.jid.2023.08.010

Role of antigenic stimulation in cutaneous T-cell lymphomas 10.1016/j.jid.2023.10.023

Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors 10.1001/jamadermatol.2023.5509

The skin molecular ecosystem holds the key to nevogenesis and melanomagenesis 10.1016/j.jid.2023.09.271

Unmet needs for patients with seborrheic dermatitis 10.1016/j.jaad.2022.12.017

Sources

Cochrane Library (Mar); JAMA Dermatology (Feb-Mar); Journal of Investigative Dermatology (Mar-Apr); Journal of the American Academy of Dermatology (Mar-Apr)

February 2024

Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis DOI: 10.1001/jamadermatol.2023.4090

A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies DOI: 10.1016/j.jaad.2023.10.021

Cutaneous granulomas associated with rubella virus DOI: 10.1016/j.jaad.2023.05.058

Cutaneous melioidosis: an updated review and primer for the dermatologist DOI: 10.1016/j.jaad.2023.07.1032

Emerging role of the IL-36/IL-36R axis in multiple inflammatory skin diseases DOI: 10.1016/j.jid.2023.11.004

Epidemiology, clinical characteristics, treatment, and outcomes of proliferating pilar tumors: A systematic review DOI: 10.1016/j.jaad.2023.05.097

Extracellular vesicles in the skin microenvironment: emerging roles as biomarkers and therapeutic tools in dermatologic health and disease DOI: 10.1016/j.jid.2023.08.024

Genomic profiling of the overlap phenotype between psoriasis and atopic dermatitis DOI: 10.1016/j.jid.2023.06.194

Inborn errors of immunity contribute to the burden of skin disease and create opportunities for improving the practice of dermatology DOI: 10.1016/j.jid.2023.08.018

Janus kinase inhibitors and adverse events of acne DOI: 10.1001/jamadermatol.2023.3830

Outcome measures for the evaluation of treatment response in hidradenitis suppurativa for clinical practice: a HiSTORIC consensus statement DOI: 10.1001/jamadermatol.2023.3282

Patient perspectives on social risk screening and documentation in a dermatology clinic DOI: 10.1001/jamadermatol.2023.3887

Pressure alopecias: A review DOI: 10.1016/j.jaad.2023.07.009

The risk of keratinocyte cancer in vitiligo and the potential mechanisms involved DOI: 10.1016/j.jid.2023.08.012

Risk of paradoxical eczema in patients receiving biologics for psoriasis DOI: 10.1001/jamadermatol.2023.4846

Risk of suicide and psychiatric disorders among isotretinoin users: a meta-analysis DOI: 10.1001/jamadermatol.2023.4579

Safety and effectiveness of oral nutraceuticals for treating acne: a systematic review DOI: 10.1001/jamadermatol.2023.3949

SARS-CoV-2–induced vasculitic skin lesions are associated with massive spike protein depositions in autophagosomes DOI: 10.1016/j.jid.2023.07.018

Sources used: JAMA Dermatology (Nov, Dec, Jan); Journal of Investigative Dermatology (Dec, Jan, Feb); Journal of the American Academy of Dermatology (Dec, Jan, Feb)